Cargando…
The Pursuit of Transparency and Quality Improvement in Cost-Effectiveness Analysis – A Case Study in Disease-Modifying Drugs for the Treatment of Multiple Sclerosis
Cost-effectiveness analysis (CEA) can be a powerful analytic tool for assessing the value of health care interventions when used in conjunction with efficacy, safety, and other supporting data in an evidence-based decision making environment. CEA is commonly defined in terms of the comparison of cos...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438292/ https://www.ncbi.nlm.nih.gov/pubmed/21787032 http://dx.doi.org/10.18553/jmcp.2011.17.6.463 |